146 related articles for article (PubMed ID: 24824137)
1. Exploiting natural products to build metalla-assemblies: the anticancer activity of embelin-derived Rh(III) and Ir(III) metalla-rectangles.
Gupta G; Kumar JM; Garci A; Nagesh N; Therrien B
Molecules; 2014 May; 19(5):6031-46. PubMed ID: 24824137
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, molecular structure, computational study and in vitro anticancer activity of dinuclear thiolato-bridged pentamethylcyclopentadienyl Rh(III) and Ir(III) complexes.
Gupta G; Garci A; Murray BS; Dyson PJ; Fabre G; Trouillas P; Giannini F; Furrer J; Süss-Fink G; Therrien B
Dalton Trans; 2013 Nov; 42(43):15457-63. PubMed ID: 24022745
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Molecular Structure and Cytotoxicity of Molecular Materials Based on Water Soluble Half-Sandwich Rh(III) and Ir(III) Tetranuclear Metalla-Cycles.
Gupta G; Murray BS; Dyson PJ; Therrien B
Materials (Basel); 2013 Nov; 6(11):5352-5366. PubMed ID: 28788394
[TBL] [Abstract][Full Text] [Related]
4. Anticancer Activity of Half-Sandwich Rh
Gupta G; Mahesh Kumar J; Garci A; Rangaraj N; Nagesh N; Therrien B
Chempluschem; 2014 Apr; 79(4):610-618. PubMed ID: 31986703
[TBL] [Abstract][Full Text] [Related]
5. Organometallic rhodium(III) and iridium(III) cyclopentadienyl complexes with curcumin and bisdemethoxycurcumin co-ligands.
Pettinari R; Marchetti F; Pettinari C; Condello F; Petrini A; Scopelliti R; Riedel T; Dyson PJ
Dalton Trans; 2015 Dec; 44(47):20523-31. PubMed ID: 26548708
[TBL] [Abstract][Full Text] [Related]
6. Anticancer activity of osmium metalla-rectangles.
Barry NP; Edafe F; Dyson PJ; Therrien B
Dalton Trans; 2010 Mar; 39(11):2816-20. PubMed ID: 20200707
[TBL] [Abstract][Full Text] [Related]
7. Anticancer Study on Ir
Kowalik M; Masternak J; Olszewski M; Maciejewska N; Kazimierczuk K; Sitkowski J; Dąbrowska AM; Chylewska A; Makowski M
Inorg Chem; 2024 Jan; 63(2):1296-1316. PubMed ID: 38174357
[TBL] [Abstract][Full Text] [Related]
8. Anticancer activity of opened arene ruthenium metalla-assemblies.
Barry NP; Zava O; Furrer J; Dyson PJ; Therrien B
Dalton Trans; 2010 Jun; 39(22):5272-7. PubMed ID: 20442944
[TBL] [Abstract][Full Text] [Related]
9. Anticancer potential of (pentamethylcyclopentadienyl)chloridoiridium(III) complexes bearing κP and κP,κS-coordinated Ph2 PCH2 CH2 CH2 S(O)x Ph (x=0-2) ligands.
Ludwig G; Ranđelović I; Maksimović-Ivanić D; Mijatović S; Bulatović MZ; Miljković D; Korb M; Lang H; Steinborn D; Kaluđerović GN
ChemMedChem; 2014 Jul; 9(7):1586-93. PubMed ID: 24470190
[TBL] [Abstract][Full Text] [Related]
10. Rhodium(III) and iridium(III) complexes with 1,2-naphthoquinone-1-oximate as a bidentate ligand: synthesis, structure, and biological activity.
Wirth S; Rohbogner CJ; Cieslak M; Kazmierczak-Baranska J; Donevski S; Nawrot B; Lorenz IP
J Biol Inorg Chem; 2010 Mar; 15(3):429-40. PubMed ID: 20091072
[TBL] [Abstract][Full Text] [Related]
11. Half Sandwich Rhodium(III) and Iridium(III) Complexes as Cytotoxic and Metallonuclease Agents.
Vekariya PA; Karia PS; Bhatt BS; Patel MN
Appl Biochem Biotechnol; 2019 Feb; 187(2):556-569. PubMed ID: 30003473
[TBL] [Abstract][Full Text] [Related]
12. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.
Pérez-Arnaiz C; Acuña MI; Busto N; Echevarría I; Martínez-Alonso M; Espino G; García B; Domínguez F
Eur J Med Chem; 2018 Sep; 157():279-293. PubMed ID: 30099251
[TBL] [Abstract][Full Text] [Related]
13. On the antitumor properties of novel cyclometalated benzimidazole Ru(II), Ir(III) and Rh(III) complexes.
Yellol GS; Donaire A; Yellol JG; Vasylyeva V; Janiak C; Ruiz J
Chem Commun (Camb); 2013 Dec; 49(98):11533-5. PubMed ID: 24177492
[TBL] [Abstract][Full Text] [Related]
14. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
[TBL] [Abstract][Full Text] [Related]
15. Cellular selectivity and biological impact of cytotoxic rhodium(III) and iridium(III) complexes containing methyl-substituted phenanthroline ligands.
Geldmacher Y; Kitanovic I; Alborzinia H; Bergerhoff K; Rubbiani R; Wefelmeier P; Prokop A; Gust R; Ott I; Wölfl S; Sheldrick WS
ChemMedChem; 2011 Mar; 6(3):429-39. PubMed ID: 21337523
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the Anticancer Activity of Coordination-Driven Self-AssembledTwo-Dimensional Ruthenium Metalla-Rectangle.
Vardhan H; Nafady A; Al-Enizi AM; Khandker K; El-Sagher HM; Verma G; Acevedo-Duncan M; Alotaibi TM; Ma S
Molecules; 2019 Jun; 24(12):. PubMed ID: 31248221
[TBL] [Abstract][Full Text] [Related]
17. Trapping unstable benzoquinone analogues by coordination to a [(η(5)-C(5)Me(5))Ir] fragment and the anticancer activity of the resulting complexes.
Hartinger CG
Angew Chem Int Ed Engl; 2010 Nov; 49(45):8304-5. PubMed ID: 20803595
[No Abstract] [Full Text] [Related]
18. Hetero-Bis-Conjugation of Bioactive Molecules to Half-Sandwich Ruthenium(II) and Iridium(III) Complexes Provides Synergic Effects in Cancer Cell Cytotoxicity.
Biancalana L; Kostrhunova H; Batchelor LK; Hadiji M; Degano I; Pampaloni G; Zacchini S; Dyson PJ; Brabec V; Marchetti F
Inorg Chem; 2021 Jul; 60(13):9529-9541. PubMed ID: 34156246
[TBL] [Abstract][Full Text] [Related]
19. Biological Potential of Halfsandwich Ruthenium(II) and Iridium (III) Complexes.
Ludwig G; Mojić M; Bulatović M; Mijatović S; Maksimović-Ivanić D; Steinborn D; Kaluđerović GN
Anticancer Agents Med Chem; 2016; 16(11):1455-1460. PubMed ID: 26510901
[TBL] [Abstract][Full Text] [Related]
20. Similarities and differences in d
Gilewska A; Barszcz B; Masternak J; Kazimierczuk K; Sitkowski J; Wietrzyk J; Turlej E
J Biol Inorg Chem; 2019 Jun; 24(4):591-606. PubMed ID: 31115765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
